Safeguard Scientifics
VC Fund
Radnor, United States
Safeguard Scientifics is a VC fund in Radnor focused on Health Care and Software. Safeguard Scientifics, Inc. (NYSE: SFE) has a distinguished track record of fostering innovation and building market leaders. For more than 60 years, Safeguard has been providing growth capital and operational support to entrepreneurs across an evolving spectrum of industries. Today, Safeguard is focused specifically on healthcare and technology.Safeguard is a proven partner for entrepreneurs looking to accelerate growth and build long-term value in their businesses. Investors in NYSE:SFE have a unique opportunity to tap into the high potential of Safeguard's early- and growth-stage partners companies.
- Total investments:
- 109
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries Safeguard Scientifics invests in
Stages Safeguard Scientifics invests in
Countries Safeguard Scientifics invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Health Care 27 (25%)
- Software 18 (17%)
- Biotechnology 16 (15%)
- Medical 15 (14%)
- Analytics 12 (11%)
Stage
- Series B 32 (29%)
- Series A 23 (21%)
- Series C 16 (15%)
- Series D 11 (10%)
- Funding Round 7 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Gary Kurtzman
Senior Vice President and Managing Director, Healthcare
|
Senior Vice President and Managing Director, Healthcare | Total investments: 25 | Find email | |
Scott Snyder
Chief Technology and Innovation Officer
|
Chief Technology and Innovation Officer | Total investments: 1 | Find email | |
Seth Zuckerman
Senior Associate, Healthcare
|
Senior Associate, Healthcare | Total investments: 0 | Find email | |
Steven J. Grenfell
SVP of Operations
|
SVP of Operations | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Prognos Health is a leading health tech company that is pushing the boundaries of healthcare analytics. The company’s platform, prognosFACTOR, has the power to query billions of lab and health records on more than 325 million de-identified patients to answer clinically-focused healthcare questions in minutes, not months. The platform enables thequerying and purchasing of patient-centric, HIPAA-Compliant healthcare data from the Prognos Marketplace to address diverse applications, including cohort design, patient journey studies, health outcomes and more. Customers include 25 of the top 30 pharmaceutical manufacturers and three of the top five payers. | $23.3M / May 04, 2023 | ||
| To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions thatmatter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond. | $35M / Venture - Series Unknown / Jul 27, 2022 | ||
| Moxe Health streamlines the bi-directional exchange of clinical data between health plans and provider systems.The company provide solutions for risk adjustment, HEDIS and Star ratings, claims denial management, HCC reconciliation, patient summary, ADT notifications, and care gap management. Plans seamlessly send back data and insights whilenever straying from clinicians’ EHR workflows.Moxe’s clinical data clearinghouse allows health plans to easily receive information from health systems. Health plans can then seamlessly send back data and insights. With automated solutions for risk adjustment, quality, and care management programs, Moxe facilitates access to the information essential to your success in the market shift to value-based care.Moxe’s neutrality in providing data connectivity lets you realize the full potential of your existing investments in population health, quality, and analytics solutions. | $30M / Series B / Jun 01, 2022 | ||
| Moxe Health streamlines the bi-directional exchange of clinical data between health plans and provider systems.The company provide solutions for risk adjustment, HEDIS and Star ratings, claims denial management, HCC reconciliation, patient summary, ADT notifications, and care gap management. Plans seamlessly send back data and insights whilenever straying from clinicians’ EHR workflows.Moxe’s clinical data clearinghouse allows health plans to easily receive information from health systems. Health plans can then seamlessly send back data and insights. With automated solutions for risk adjustment, quality, and care management programs, Moxe facilitates access to the information essential to your success in the market shift to value-based care.Moxe’s neutrality in providing data connectivity lets you realize the full potential of your existing investments in population health, quality, and analytics solutions. | Venture - Series Unknown / Jan 11, 2021 | ||
| To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions thatmatter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond. | $30M / Series F / May 28, 2020 | ||
| Trice Medical is founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payor by providing instant, eyes-on, answers. Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physician's office. Their mission is to provide more immediate anddefinitive patient care, eliminating the false reads associated with current indirect modalities and significantly reducing the overall cost to the healthcare system.Trice Medical was founded in 2011 and is based in Pennsylvania. | $18.3M / Series C / Jan 14, 2019 | ||
| InfoBionic transforms the efficiency and the economics of ambulatory remote patient monitoring processes and cardiac diagnostic services by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. It has developed the MoMe System, a remote patient monitoring platform initially focused on cardiacarrhythmia detection, to improve clinical efficiency and patient care with any time, anywhere access to patient data. | $50M / Venture - Series Unknown / Sep 12, 2018 | ||
| Zipnosis is a hospital and healthcare company that specializes in online diagnosis and triage, telehealth, and virtual care. So Zipnosis created device-agnostic virtual care that offers patients greater choice and convenience, offers providers improved efficiency, and boosts the bottom line for health organizations.The company was founded in 2009and headquartered in Minnesota, United States. | $3M / Series B / Aug 17, 2018 | ||
| meQuilibrium offers individuals and employees online stress management solutions and measurements. It is the only clinically validated resilience platform leveraging behavioral psychology, neuroscience, and analytics to deliver transformative insights that change lives and businesses. | $7M / Series C / Aug 14, 2018 | ||
| Propeller Health is a mobile platform that offers sensors, mobile apps, analytics, and services to support respiratory health management. The HIPAA compliant platform stores users’ data in a cloud computing infrastructure.The Propeller sensor and mobile application help users learn more about and better manage their asthma, COPD, andrespiratory disease. The Propeller sensor attaches to users’ inhalers and wirelessly syncs with their smartphones. It tracks their triggers and symptoms and sends personalized feedback and education to their phones based on the symptoms. Users can see how often they use the medication, and set up medication reminders and alerts.Propeller community enables users to share their Propeller data with their physician and family members.Propeller Health is backed by Safeguard Scientifics, The Social+Capital Partnership, California HealthCare Foundation, and other investors. The platform works with organizations such as Dignity Health, Wyckoff Heights Medical Center, Amerigroup Florida, and the City of Louisville. The system has been featured in The Economist, Washington Post, Fast Company, Wired, and Scientific American.Propeller Health has received TEDMED Innovation Showcase, White House Champion of Change, and Bluetooth Breakthrough Product awards.Propeller Health was launched by David Van Sickle, Greg Tracy, and Mark Gehring and its operations are based in Wisconsin, United States. | $20M / Series D / May 30, 2018 | ||
| See all 109 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Safeguard Scientifics invest in?
Safeguard Scientifics invests primarily in Health Care, Software and Biotechnology startups, most often at Series B and Series A stage. Most of the 109 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Safeguard Scientifics?
Public channels for Safeguard Scientifics include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Safeguard Scientifics?
The team at Safeguard Scientifics includes Gary Kurtzman (Senior Vice President and Managing Director, Healthcare), Scott Snyder (Chief Technology and Innovation Officer) and Seth Zuckerman (Senior Associate, Healthcare). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
